$0.265
+0.0139 (+5.54%)
At Close: Jun 22, 2026
Algernon Pharmaceuticals Earnings Calls
May 31, 2026
(Upcoming)
| Release date | Jul 24, 2026 |
| EPS estimate | -$4.97 |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
| Expected change | +/- 8.78% |
Feb 28, 2026
-$0.0806 (83.81%)
| Release date | Apr 27, 2026 |
| EPS estimate | -$0.498 |
| EPS actual | -$0.0806 |
| EPS Surprise | 83.81% |
| Revenue estimate | - |
| Revenue actual | - |
Nov 30, 2025
| Release date | Jan 29, 2026 |
| EPS estimate | - |
| EPS actual | -$0.122 |
| Revenue estimate | - |
| Revenue actual | - |
Aug 31, 2025
| Release date | Aug 30, 2025 |
| EPS estimate | - |
| EPS actual | -$0.0141 |
| Revenue estimate | - |
| Revenue actual | - |
Last 4 Quarters for Algernon Pharmaceuticals
Below you can see how AGNPF performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
Aug 31, 2025
| Release date | Aug 30, 2025 |
| Price on release | $0.400 |
| EPS estimate | - |
| EPS actual | -$0.0141 |
| Date | Price |
|---|---|
| Aug 25, 2025 | $0.486 |
| Aug 26, 2025 | $0.486 |
| Aug 27, 2025 | $0.465 |
| Aug 28, 2025 | $0.497 |
| Aug 29, 2025 | $0.400 |
| Sep 02, 2025 | $0.496 |
| Sep 03, 2025 | $0.400 |
| Sep 04, 2025 | $0.480 |
| Sep 05, 2025 | $0.480 |
| 4 days before | -17.70% |
| 4 days after | 20.00% |
| On release day | 24.00% |
| Change in period | -1.23% |
Nov 30, 2025
| Release date | Jan 29, 2026 |
| Price on release | $0.368 |
| EPS estimate | - |
| EPS actual | -$0.122 |
| Date | Price |
|---|---|
| Jan 23, 2026 | $0.395 |
| Jan 26, 2026 | $0.382 |
| Jan 27, 2026 | $0.382 |
| Jan 28, 2026 | $0.372 |
| Jan 29, 2026 | $0.368 |
| Jan 30, 2026 | $0.361 |
| Feb 02, 2026 | $0.361 |
| Feb 03, 2026 | $0.361 |
| Feb 04, 2026 | $0.361 |
| 4 days before | -6.84% |
| 4 days after | -1.90% |
| On release day | -1.90% |
| Change in period | -8.61% |
Feb 28, 2026
Beat
| Release date | Apr 27, 2026 |
| Price on release | $0.0357 |
| EPS estimate | -$0.498 |
| EPS actual | -$0.0806 |
| EPS surprise | 83.81% |
| Date | Price |
|---|---|
| Apr 21, 2026 | $0.0357 |
| Apr 22, 2026 | $0.0357 |
| Apr 23, 2026 | $0.0357 |
| Apr 24, 2026 | $0.0357 |
| Apr 27, 2026 | $0.0357 |
| Apr 28, 2026 | $0.0357 |
| Apr 29, 2026 | $0.0357 |
| Apr 30, 2026 | $0.0357 |
| May 01, 2026 | $0.0357 |
| 4 days before | 0% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | 0% |
May 31, 2026
(Upcoming)
| Release date | Jul 24, 2026 |
| Price on release | - |
| EPS estimate | -$4.97 |
| EPS actual | - |
| Date | Price |
|---|---|
| Jun 15, 2026 | $0.440 |
| Jun 16, 2026 | $0.440 |
| Jun 17, 2026 | $0.380 |
| Jun 18, 2026 | $0.251 |
| Jun 22, 2026 | $0.265 |
Algernon Pharmaceuticals Earnings History
Earnings Calendar
FAQ
When is the earnings report for AGNPF?
Algernon Pharmaceuticals Inc. (AGNPF) has scheduled its earnings report for Jul 24, 2026 after the markets close.
What is the AGNPF price-to-earnings (P/E) ratio?
AGNPF P/E ratio as of Jun 22, 2026 (TTM) is -0.0728.
What is the AGNPF EPS forecast?
The forecasted EPS (Earnings Per Share) for Algernon Pharmaceuticals Inc. (AGNPF) for the first fiscal quarter 2026 is -$4.97.
What are Algernon Pharmaceuticals Inc.'s retained earnings?
On its balance sheet, Algernon Pharmaceuticals Inc. reported retained earnings of $0 for the latest quarter ending Feb 28, 2026.
What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.
Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.
What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
Sign In
Buy AGNPF